iCONNECT with Baxter Canada

From Efficiency Gains to Enhanced Patient Safety: Addressing Staffing Shortages with Frozen Ready-to-Use Premixes

29 min · 10. marras 2023
jakson From Efficiency Gains to Enhanced Patient Safety: Addressing Staffing Shortages with Frozen Ready-to-Use Premixes kansikuva

Kuvaus

In this episode, Pharmacy Manager Dr. Neubauer will share her experience of being the first to implement frozen IV premixes within the Saskatchewan Health Authority. She will explain how her community hospital site first got involved, explain how they navigated through change management despite staffing shortages, and provide considerations for other organizations looking to introduce these products.

Kommentit

0

Ole ensimmäinen kommentoija

Rekisteröidy nyt ja liity iCONNECT with Baxter Canada-yhteisöön!

Aloita nyt

1 kuukausi hintaan 1 €

Sitten 7,99 € / kuukausi · Peru milloin tahansa.

  • Podimon podcastit
  • 20 kuunteluaikaa / kuukausi
  • Lataa offline-käyttöön

Kaikki jaksot

31 jaksot

jakson Improving the Safety of High Risk Insulin Infusions with Dr. Kevin Hansen kansikuva

Improving the Safety of High Risk Insulin Infusions with Dr. Kevin Hansen

IV Insulin has been defined as a top-rated high-alert medication by the Institute for Safe Medication Practices, and yet options to improve the safety of these infusions have been limited until recently.  Dr. Kevin Hansen will discuss his experience using Myxredlin, a ready-to-administer insulin infusion product that has changed how many organizations manage these high-risk infusions in the US.  He will also introduce some of the concepts for consideration when organizations are exploring the introduction of ready-to-administer products including patient safety, pharmaco-economics, drug stability, human resource management, and workflows. Link to discussed publication:  https://www.pppmag.com/article/2655 [https://www.pppmag.com/article/2655]

5. kesä 202323 min